JPMorgan Reinstates Emergent BioSolutions (EBS) at Underweight
JPMorgan analyst Jessica Fye reinstates coverage on Emergent BioSolutions ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
